Clinical implications of environmental sources for Aspergillus

Medical Mycology

Volumn 43, Issue SUPPL.1, 2005, Pages

  Warris, A ^a   Verweij, P E ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Aspergillosis; Environment; Prevention

Indexed keywords

ARTICLE; ASPERGILLOSIS; ASPERGILLUS; COMMUNICABLE DISEASE; DIAGNOSTIC TEST; ENVIRONMENTAL FACTOR; FUNGUS TRANSMISSION; HOSPITAL INFECTION; HOST SUSCEPTIBILITY; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; MOULD; NONHUMAN; SUBSPECIES; TREATMENT PLANNING;

ASPERGILLOSIS; ASPERGILLUS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; ENVIRONMENTAL EXPOSURE; HUMANS;

ASPERGILLUS;

EID: 22844453103     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/13693780400025260     Document Type: Article

References (65)

1. Beck-Sagué CM, Jarvis WR, NNISS. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J Infect Dis 1993; 167: 1247-1251.
2. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26: 781-805.
3. Groll AH, Shah PM, Mentzel C, et al. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996; 33: 23-32.
4. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34: 909-917.
5. Wald A, Leisenring W, van Burik JA, Bowden RA. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997; 175: 1459-1466.
6. Paterson DL, Singh N. Invasive aspergillosis in transplant recipients. Medicine 1999; 78: 123-138.
7. Mehrad B, Paciocco G, Martinez FJ, et al. Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature. Chest 2001; 119: 169-175.
8. Bernard A, Caillot D, Couaillier JF, et al. Surgical management of invasive pulmonary aspergillosis in neutropenic patients. Ann Thorac Surg 1997; 64: 1441-1447.
9. Denning DW. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 1996; 23: 608-615.
10. Harousseau JL, Dekker AW, Stamatoullas-Bastard A, et al. Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B. Antimicrob Agents Chemother 2000; 44: 1887-1893.
11. Morgenstern GR, Prentice AG, Prentice HG, et al. A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group. Br J Haematol 1999; 105: 901-911.
12. Bow EJ, Laverdiere M, Lussier N, et al. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials. Cancer 2002; 94: 3230-3246.
13. Gotzsche PC, Krogh Johansen H. Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia. Brit Med J 1997; 314: 1238-1244.
14. Verweij PE, Warris A, Weemaes CMR. Preventing fungal infections in chronic granulomatous disease. N Eng J Med 2003; 349: 1190-1191.
15. Patterson JE, Zidouh A, Miniter P, Andriole VT, Patterson TF. Hospital epidemiologic surveillance for invasive aspergillosis: patient demographics and the utility of antigen detection. Infect Control Hosp Epidemiol 1997; 18: 104-108.
16. Einsele H, Quabeck K, Muller KD, et al. Prediction of invasive pulmonary aspergillosis from colonisation of lower respiratory tract before marrow transplantation. Lancet 1998; 352: 1443.
17. Bennett JE. Aspergillus species. In: Mandell GL, Bennet JE, Dolin R (eds). Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. New York: Churchill Livingstone, 1995: 2306-2311.
18. Rhame FS, Streifel AJ, Kersey JH Jr., McGlave PB. Extrinsic risk factors for pneumonia in the patient at high risk of infection. Am J Med 1984; 76: 42-52.
19. Aisner J, Murillo J, Schimpff SC, Steere AC. Invasive aspergillosis in acute leukemia: correlation with nose cultures and antibiotic use. Ann Intern Med 1979; 90: 4-9.
20. Martino P, Raccah R, Gentile G, et al. Aspergillus colonization of the nose and pulmonary aspergillosis in neutropenic patients: a retrospective study. Haematologica 1989; 74: 263-265.
21. Leenders A, van Belkum A, Janssen S, et al. Molecular epidemiology of apparent outbreak of invasive aspergillosis in a hematology ward. J Clin Microbiol 1996; 34: 345-351.
22. Sherertz RJ, Belani A, Kramer BS, et al. Impact of air filtration on nosocomial Aspergillus infections. Am J Med 1987; 83: 709-718.
23. Withington S, Chambers ST, Beard ME, et al. Invasive aspergillosis in severely neutropenic patients over 18 years: impact of intranasal amphotericin B and HEPA filtration. J Hosp Infect 1998; 38: 11-18.
24. Cornet M, Levy V, Fleury L, et al. Efficacy of prevention by high-efficiency particulate air filtration or laminar airflow against Aspergillus airborne contamination during hospital renovation. Infect Control Hosp 1999; 20: 508-513.
25. Hospenthal DR, Kwon-Chung KJ, Bennett JE. Concentration of airborne Aspergillus compared to the incidence of invasive aspergillosis: lack of correlation. Med Mycol 1998; 36: 165-168.
26. Alberti C, Bouakline A, Ribaud P, et al. Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in haematology patients. J Hosp Infect 2001; 48: 198-206.
27. Oren I, Haddad N, Finkelstein R, Rowe JM. Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters. Am J Hematol 2001; 66: 257-62.
28. Buffington J, Reporter R, Lasker BA, et al. Investigation of an epidemic of invasive aspergillosis: utility of molecular typing with the use of random amplified polymorphic DNA probes. Pediatr Infect Dis J 1994; 13: 386-393.
29. Girardin H, Sarfati J, Traoré F, et al. Molecular epidemiology of nosocomial invasive aspergillosis. J Clin Microbiol 1994; 32: 684-690.
30. Radford SA, Johnson EM, Leeming JP, et al. Molecular epidemiological study of Aspergillus fumigatus in a bone marrow transplantation unit by PCR amplification of ribosomal intergenic spacer sequences. J Clin Microbiol 1998; 36: 1294-1299.
31. Rath PM, Ansorg R. Value of environmental sampling and molecular typing of aspergilli to assess nosocomial sources of aspergillosis. J Hosp Infect 1997; 37: 47-53.
32. Mellado E, Diaz-Guerra TM, Cuenca-Estrella M, et al. Characterization of a possible nosocomial aspergillosis outbreak. Clin Microbiol Infect 2000; 6: 543-548.
33. Chazalet V, Debeaupuis JP, Sarfati J, et al. Molecular typing of environmental and patient isolates of Aspergillus fumigatus from various hospital settings. J Clin Microbiol 1998; 36: 1494-1500.
34. Debeaupuis J, Sarfati J, Chazalet V, Latgé JP. Genetic diversity among clinical and environmental isolates of Aspergillus fumigatus. Infect Immun 1997; 65: 3080-3085.
35. Warris A, Voss A, Verweij PE. Hospital sources of Aspergillus: New routes of transmission. Review. Rev Iberoam Micol 2001; 18: 156-62.
36. Nagy LA, Olson BH. The occurrence of filamentous fungi in drinking water distribution systems. Can J Microbiol 1982; 28: 667-671.
37. Geldreich EE. Biological profiles in drinking water. In: Microbial quality of water supply in distribution systems. Boca Raton, Florida: CRC Lewis, 1996: 103-158.
38. Warris A, Gaustad P, Meis JFGM, et al. Recovery of filamentous fungi from water in a paediatric bone marrow transplantation unit. J Hosp Infect 2001; 47: 143-148.
39. Anaissie EJ, Stratton SL, Dignani MC, et al. Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective study. Clin Infect Dis 2002; 34: 780-789.
40. Panagopoulou P, Filioti J, Petrikkos G, et al. Environmental surveillance of filamentous fungi in three tertiary care hospitals in Greece. J Hosp Infect 2002; 52: 185-191.
41. Arvanitidou M, Spaia S, Velegraki A, et al. High level of recovery of fungi from water and dialysate in haemodialysis units. J Hosp Infect 2000; 45: 225-230.
42. Arvanitidou M, Kanellou K, Constantinides TC, et al. The occurence of fungi in hospital and community potable water. Lett Appl Microbiol 1999; 29: 81-84.
43. Bambauer R, Schauer M, Jung WK, et al. Contamination of dialysis water and dialysate. A survey of 30 centers. ASAIO J 1994; 40: 1012-1016.
44. Klein E, Pass T, Harding GB, et al. Microbial and endotoxin contamination in water and dialysates in the central United States. Artif Organs 1990; 14: 85-94.
45. Doggett MS. Characterization of fungal biofilms within a municipal water distribution system. Appl Environ Microbiol 2000; 66: 1249-1251.
46. Philips G, McEwan H, McKay I, Crowe G, McBeath J. Black pigmented fungi in the water pipe-work supplying endoscope washer disinfectors. J Hosp Infect 1998; 40: 250-251.
47. Warris A, Voss A, Abrahamsen TG, Verweij PE. Contamination of hospital water with Aspergillus fumigatus and other molds. Clin Infect Dis 2002; 34: 1159-1160.
48. ter Maaten JC, Golding RP, Strack van Schijndel RJM, Thijs LG. Disseminated aspergillosis after near-drowning. Neth J Med 1995; 47: 21-24.
49. Vieira DF, Van Saene HKF, Miranda DR. Invasive pulmonary aspergillosis after near-drowning. Int Care Med 1984; 10: 203-204.
50. Chambon-Pautas C, Costa JM, Chaumette MT, et al. Galactomannan and polymerase chain reaction for the diagnosis of primary digestive aspergillosis in a patient with acute myeloid leukaemia. J Infect 2001; 43: 213-214.
51. Fortun J, Martin-Davila P, Alvarez ME, et al. Aspergillus antigenemia sandwich-enzyme immunoassay test as a serodiagnostic method for invasive aspergillosis in liver transplant recipients. Transplant 2001; 71: 145-149.
52. van Burik JAH, Colven R, Spach DH. Cutaneous aspergillosis. J Clin Microbiol 1998; 36: 3115-3121.
53. Warris A, Klaassen CHW, Meis JFGM, et al. Molecular epidemiology of Aspergillus fumigatus isolates recovered from water, air and patients shows two clusters of genetically distinct strains. J Clin Microbiol 2003; 41: 4101-4106.
54. Bart-Delabesse E, Sarfati J, Debeaupuis JP, et al. Comparison of restriction fragment length polymorphism, microsatellite length polymorphism, and random amplification of polymorphic DNA analyses for fingerprinting Aspergillus fumigatus isolates. J Clin Microb 2001; 39: 2683-2686.
55. Savelkoul PHM, Aarts HJM, de Haas J, et al. Amplified-fragment length polymorphism analysis: the state of an art. J Clin Microbiol 1999; 37: 3083-3091.
56. Boekhout T, Theelen B, Diaz M, et al. Hybrid genotypes in the pathogenic yeast Cryptococcus neoformans. Microbiol 2001; 147: 891-907.
57. Anaissie EJ, Stratton SL, Dignani MC, et al. Cleaning patient shower facilities: a novel approach to reducing patient exposure to aerosolized Aspergillus species and other opportunistic molds. Clin Infect Dis 2002; 35: 86-88.
58. Centers for Disease Control and Prevention. Guidelines for environmental infection control in health-care facilities: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR 2003; 52: 1-48.
59. Fujikawa H, Aketagawa J, Nakazato M, et al. Growth of moulds inoculated into commercial mineral water. Lett Appl Microbiol 1999; 28: 211-215.
60. Cabral D, Fernández Pinto VE. Fungal spoilage of bottled mineral water. Int J Food Microbiol 2002; 72: 73-76.
61. Klont RR, Rijs AJMM, Warris A, Sturm PDJ, Verweij PE. Bacterial and fungal contamination of commercial bottled mineral water from 16 countries. Abstract. 44th Interscience Conference on Antimicrobials Agents and Chemotherapy. 2004. Washington, USA.
62. Anaissie EJ, Penzak SR, Dignani MC. The hospital water supply as a source of nosocomial infections. A plea for action. Arch Intern Med 2002; 162: 1483-1492.
63. Engelhart S, Krizek I, Glasmacher A, Fischnaller E, Marklein G, Exner M. Pseudomonas aeruginosa outbreak in a hematology-oncology unit associated with contaminated surface cleaning equipment. J Hosp Infect 2002; 52: 93-98.
64. Campins M, Ferrer A, Callis L, et al. Nosocomial Legionnaire's disease in a children's hospital. Ped Infect Dis J 2000; 19: 223-224.
65. Eshuis F, Potzsch K, Aerts E, Colombo C. Positive water samples for Legionella pneumophilia in a bone marrow transplant ward, University Hospital, Switzerland. Bone Marrow Transpl 2003; S1: 993.